Literature DB >> 8437029

Determinants of wound infection in gastrointestinal operations: the Israeli study of surgical infections.

Y Siegman-Igra1, R Rozin, E Simchen.   

Abstract

Risk factors for wound infection in operations involving the opening of the gastrointestinal (GI) tract, were explored in a prospective study. There were 813 consecutive operations performed during a period of 9-14 months in 11 Israeli hospitals. The total crude infection rate was 21.6%, and the respective rates for operations on the stomach, small bowel and colon were 14.8, 21.4 and 25.4%. Of 17 putative risk factors, the strongest predictor was the performance of 2 or more operations during the same admission. Other significant risk factors were: a diagnosis of intestinal obstruction or perforation, introduction of an open drain, emergency admission, age over 40, hospital stay prior to surgery 7 or more days, urinary catheter and infection on admission. Adjustment for these factors in a logistic regression model reduced the effect of the anatomical site of the operation (i.e. large bowel vs stomach) to a non-significant level.

Entities:  

Mesh:

Year:  1993        PMID: 8437029     DOI: 10.1016/0895-4356(93)90051-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

Review 1.  A multi-disciplinary review of the potential association between closed-suction drains and surgical site infection.

Authors:  Alyssa J Reiffel; Philip S Barie; Jason A Spector
Journal:  Surg Infect (Larchmt)       Date:  2013-05-29       Impact factor: 2.150

2.  Peritoneal inflammatory response of natural orifice translumenal endoscopic surgery (NOTES) versus laparoscopy with carbon dioxide and air pneumoperitoneum.

Authors:  Joseph A Trunzo; Michael F McGee; Leandro T Cavazzola; Steve Schomisch; Mehrdad Nikfarjam; Jessica Bailey; Tripurari Mishra; Benjamin K Poulose; Young-Joon Lee; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.